IFNα8 and IFNα14 reduced HIV-1 infection levels to ~30% at the maximal doses tested (10 ng/ml), whereas IFNα1, IFNα2 and IFNβ had higher Vres between 38–42%. Here, IFNB1 is linked to HIV-1 infection.